Literature DB >> 23509315

Disease-free survival in colon cancer: still relevant after all these years!

Axel Grothey, Aimery de Gramont, Daniel J Sargent.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23509315     DOI： 10.1200/JCO.2012.47.4452

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

Review 1.  Clinical Benefit Scales and Trial Design: Some Statistical Issues.

Authors:  Edward L Korn; Carmen J Allegra; Boris Freidlin
Journal:  J Natl Cancer Inst       Date:  2022-09-09       Impact factor: 11.816

2.  Comparison of outcomes after fluorouracil-based adjuvant therapy for stages II and III colon cancer between 1978 to 1995 and 1996 to 2007: evidence of stage migration from the ACCENT database.

Authors:  Qian Shi; Thierry Andre; Axel Grothey; Greg Yothers; Stanley R Hamilton; Brian M Bot; Daniel G Haller; Eric Van Cutsem; Chris Twelves; Jacqueline K Benedetti; Michael J O'Connell; Daniel J Sargent
Journal:  J Clin Oncol       Date:  2013-08-26       Impact factor: 44.544

3.  CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer.

Authors:  Minh Nam Nguyen; Tae Gyu Choi; Dinh Truong Nguyen; Jin-Hwan Kim; Yong Hwa Jo; Muhammad Shahid; Salima Akter; Saurav Nath Aryal; Ji Youn Yoo; Yong-Joo Ahn; Kyoung Min Cho; Ju-Seog Lee; Wonchae Choe; Insug Kang; Joohun Ha; Sung Soo Kim
Journal:  Oncotarget       Date:  2015-10-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.